Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants
- PMID: 9892697
- PMCID: PMC15200
- DOI: 10.1073/pnas.96.2.703
Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants
Abstract
Rapid production of protein-based tumor-specific vaccines for the treatment of malignancies is possible with the plant-based transient expression system described here. We created a modified tobamoviral vector that encodes the idiotype-specific single-chain Fv fragment (scFv) of the immunoglobulin from the 38C13 mouse B cell lymphoma. Infected Nicotiana benthamiana plants contain high levels of secreted scFv protein in the extracellular compartment. This material reacts with an anti-idiotype antibody by Western blotting, ELISA, and affinity chromatography, suggesting that the plant-produced 38C13 scFv protein is properly folded in solution. Mice vaccinated with the affinity-purified 38C13 scFv generate >10 micrograms/ml anti-idiotype immunoglobulins. These mice were protected from challenge by a lethal dose of the syngeneic 38C13 tumor, similar to mice immunized with the native 38C13 IgM-keyhole limpet hemocyanin conjugate vaccine. This rapid production system for generating tumor-specific protein vaccines may provide a viable strategy for the treatment of non-Hodgkin's lymphoma.
Figures





Similar articles
-
Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.J Immunol. 1987 Oct 15;139(8):2825-33. J Immunol. 1987. PMID: 3498771
-
Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig.J Immunol Methods. 2003 Jul;278(1-2):95-104. doi: 10.1016/s0022-1759(03)00208-4. J Immunol Methods. 2003. PMID: 12957399
-
Rapid production of single-chain Fv fragments in plants using a potato virus X episomal vector.J Immunol Methods. 1999 Dec 10;231(1-2):137-46. doi: 10.1016/s0022-1759(99)00150-7. J Immunol Methods. 1999. PMID: 10648933
-
The development of a bicistronic plasmid DNA vaccine for B-cell lymphoma.Vaccine. 2002 Jan 31;20(9-10):1400-11. doi: 10.1016/s0264-410x(01)00464-9. Vaccine. 2002. PMID: 11818159
-
Translational development of vaccination strategies in follicular NHL.Best Pract Res Clin Haematol. 2011 Jun;24(2):295-304. doi: 10.1016/j.beha.2011.03.007. Epub 2011 May 6. Best Pract Res Clin Haematol. 2011. PMID: 21658625 Review.
Cited by
-
Use of viral vectors for vaccine production in plants.Immunol Cell Biol. 2005 Jun;83(3):263-70. doi: 10.1111/j.1440-1711.2005.01339.x. Immunol Cell Biol. 2005. PMID: 15877604 Free PMC article. Review.
-
Immunization with a plant-produced colorectal cancer antigen.Cancer Immunol Immunother. 2004 Feb;53(2):92-9. doi: 10.1007/s00262-003-0428-1. Epub 2003 Oct 18. Cancer Immunol Immunother. 2004. PMID: 14566428 Free PMC article.
-
Vaccination against Epstein-Barr Latent Membrane Protein 1 Protects against an Epstein-Barr Virus-Associated B Cell Model of Lymphoma.Biology (Basel). 2023 Jul 11;12(7):983. doi: 10.3390/biology12070983. Biology (Basel). 2023. PMID: 37508413 Free PMC article.
-
Intracellular reprogramming of expression, glycosylation, and function of a plant-derived antiviral therapeutic monoclonal antibody.PLoS One. 2013 Aug 15;8(8):e68772. doi: 10.1371/journal.pone.0068772. eCollection 2013. PLoS One. 2013. PMID: 23967055 Free PMC article.
-
Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge.Hum Vaccin Immunother. 2014;10(3):586-95. doi: 10.4161/hv.27567. Epub 2013 Dec 30. Hum Vaccin Immunother. 2014. PMID: 24378714 Free PMC article.
References
-
- Ries L A G, Kosary C L, Hankey B F, Harras A, Miller B A, Edwards B K, editors. SEER Cancer Statistics Review, 1973–1993: Tables and Graphs. Bethesda: Natl. Cancer Inst.; 1996.
-
- Parker S L, Tong T, Bolden S, Wingo P A. CA Cancer J Clin. 1997;47:5–27. - PubMed
-
- Armitage J O. CA Cancer J Clin. 1997;47:323–325. - PubMed
-
- Kwak L W, Campbell M J, Czerwinski D K, Hart S, Miller R A, Levy R. N Engl J Med. 1992;327:1209–1215. - PubMed
-
- Hsu F J, Kwak L, Campbell M, Liles T, Czerwinski D, Hart S, Syrengelas A, Miller R, Levy R. Ann N Y Acad Sci. 1993;690:385–387. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical